Regulatory Clearance ≠ Clinical Benefit: The State of AI-Enabled ICU Devices

MedAI Digest
MedAI Digest
Regulatory Clearance ≠ Clinical Benefit: The State of AI-Enabled ICU Devices
Loading
/

A systematic review of 36 commercially available AI-enabled medical devices designed for intensive care reveals a fragmented regulatory landscape across the US and EU—with a critical gap between regulatory clearance and proven clinical utility.

Original paper: The landscape of artificial intelligence-enabled medical devices in the EU and the US intended for intensive care units. — NPJ digital medicine. 10.1038/s41746-026-02609-2

📄 Read the article

Trending now

Quantitative pathology and APOE genotype reveal dementia risk and progression in Lewy body disease.
APOE Genotype and Protein Pathology Shape Dementia Risk in Lewy Body Disease
Transfer-learning guided design of high-performance conjugated polymers for low-voltage electrochemical transistors.
Machine Learning Accelerates Discovery of Ultra-Low-Voltage Polymers
Soft multiclass feature augmented deep learning to predict tumor origins using cytology or histology whole slide images.
AI Identifies Tumor Origins from Tissue Images with 98% Accuracy
AI-guided multi-omics analysis identifies NPC1-modulated susceptibility to SARS-CoV-2 infection under PM2.5 exposure.
Air Pollution and COVID-19: How NPC1 Mediates SARS-CoV-2 Infection Risk